Essity AB (ESSITY B)

Nasdaq Stockholm | Hygiene and health products
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.
Free
No email, no account, no signup.
Pulling latest news for Essity AB…
Bull
Bear
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.

Professional stock analysis at introductory pricing. 7-day money-back guarantee — no lock-in.

Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99 $1.25.
Get the deep 4-model report – $4.99 $1.25
Signal
HOLD
Sentiment
6/10
Risk
4/10
Get full analysis with Bull/Bear case, catalysts, and risk analysis
Buy express analysis – $4.99 $1.25
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Sentiment remains neutral to slightly positive: insider buying supports confidence, but the higher capex increases concerns about lower near-term free cash flow.
Exchange
Nasdaq Stockholm
Sector
Hygiene and health products
Market Cap
$18.0B

9 days ago 19 Jun 2026

Market sentiment

Sentiment remains neutral to slightly positive: insider buying supports confidence, but the higher capex increases concerns about lower near-term free cash flow.

Why HOLD ?

- **Hold**: defensive, cash-generative business with improving margins - Near-term upside depends on **Q1** and clearer volume recovery - Risk/reward looks balanced given maturity and competition
  • Hold current position; consider adding after Q1/Capital Markets Day if volumes and margins are confirmed.

Recent News

  • Since 2026-05-12, Essity’s updates have mainly been ongoing disclosures on the SEK 3bn share buyback program (including repurchases in weeks 22–24 of roughly 0.31–0.32m B-shares per week). The share price has moved up from ~SEK 256–259 in late May to ~SEK 267–269 in mid-June. The strategic review of Consumer Tissue (potential separation/divestment) remains the key catalyst, and the next report is Q2 on 16 July 2026.

Bull case

- **Q1 earnings** could confirm continued margin strength - **Share buybacks** provide technical support and EPS uplift - Early positive read-through from **Edgewell integration**
Unlock to read more →

Bear case

- Weak volumes and **pricing pressure** in tissue - **Input/energy costs** could turn volatile - Macro pressure may drive **downtrading** to private label
Unlock to read more →

Catalysts

1 Jan 2027 — Falkenberg central logistics hub (go-live)

Unlock 3 more catalysts →

Dilution Risk

Assessment: Low

Order analysis – $4.99 $1.25
Save hours of research. $4.99 $1.25.
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Intro rate Introductory pricing for early customers through June 30 — the same full analysis at a lower rate while we refine delivery.

Want to read the full analysis?

Order a fresh analysis of Essity AB – ready in your inbox in 5–15 minutes.

  • Signal + risk + sentiment
  • Bull/Bear case + triggers
  • Catalysts with dates
  • Saved as a webpage in your account
  • Ready in 5–15 min (email when ready)

Full analysis at introductory pricing — 7-day money-back guarantee.

7-day money-back guarantee · No lock-in period · Secure payment via Stripe

Fact-based analysis Updated weekly No commitment period
Essity AB (ESSITY B)
HOLD
Buy express analysis – $4.99 $1.25
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.